SCHEMBL6818015

SCHEMBL6818015

COc1ccc(-c2ccnc(NCCCC3CCC3)c2N)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 4/20 0.36
HSP90AA1 P07900 2/20 0.36
HSP90AB1 P08238 2/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CHRNB2 P17787 2/20 0.35
CHRNB4 P30926 2/20 0.35
CHRNA3 P32297 2/20 0.35
CHRNA4 P43681 2/20 0.35
KCNH2 Q12809 2/20 0.35
DRD4 P21917 1/20 0.35
SLC6A2 P23975 1/20 0.35
KMT5A Q9NQR1 1/20 0.34
CRHR1 P34998 1/20 0.34
CRHR2 Q13324 1/20 0.34
CDC7 O00311 1/20 0.34
CCNT1 O60563 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817533 0.96 HSP90AA1 (0.37) ACP1HSP90AA1HSP90AB1CHRNB2CHRNB4
SCHEMBL6817674 0.84 CRHR1 (0.36) CRHR1CRHR2CCNT1
SCHEMBL6817700 0.84 MAPT (0.35) ACP1NPC1RAB9ACHRNB2CHRNB4
SCHEMBL6817777 0.82 BRD4 (0.37) CRHR1BRD4HTR1AADRA1DADRA1A
SCHEMBL6818255 0.82 CRHR1 (0.36) CRHR1CRHR2CCNT1
SCHEMBL6817664 0.81 KMT5A (0.34) ACP1HSP90AA1HSP90AB1KMT5ACRHR1
SCHEMBL6817843 0.80 SCN9A (0.37) ACP1KMT5ACRHR1CCNT1CDK9
SCHEMBL6821870 0.80 ENPP1 (0.36) HSP90AA1HSP90AB1CHRNB2CHRNB4CHRNA3
SCHEMBL6817921 0.80 MAPT (0.36) NPC1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL6813647 0.80 ACP1 (0.43) ACP1NPC1RAB9ACRHR1CRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004031189-A1 PYRIDINO AND PYRIMIDINO PYRAZINONES FOR TREATMENT OF ANXIETY AND DEPRESSION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2004-04-15 WO disclosed